On Demand 2017 Obstructive Lung Disease (MOC)

Price: $25 members, $35 non-members

You can earn up to 1.25 AMA PRA Category 1 Credits™, and up to 1.25 MOC Part II Self-Assessment credits. 

This session examines the evidence for treatment of obstructive lung disease.

  • GINA 2017: How Will This Change My Practice?
  • GOLD 2017: How Will This Change My Practice?

Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 1.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Of the AMA PRA Category 1 Credits™ listed above, the ABAI has designated a maximum of 1.25 credits as meeting the requirements for MOC Part II Self-Assessment.

    Target Audience

    Medical professionals who treat patients with allergic and/or immunological conditions:

    • Practicing allergist/immunologists
    • Allergy/immunology Fellows-in-Training
    • Physician assistants
    • Nurses and advanced practice nurses
    • Allied health professionals
    • Primary care physicians
    • Other medical professionals

    Learning Objectives

    Upon completion of this session, participants should be able to:

    • Evaluate the potential positive outcomes from GINA add-on therapy.
    • Choose the patient population that will not have sufficient burden of disease to necessitate GOLD therapy.
    • Evaluate all of the evidence to provide guidance for appropriate cost-effective use of these medications.
    Additional information
    Disclosure: 

    As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (College) policy, the College must identify and resolve conflicts of interest for all individuals responsible for the development, management, presentation, or evaluation of content for a CME activity. Financial disclosures are reviewed in advance, to ensure any potential conflicts of interest are resolved. Disclosure in no way implies that the information presented is biased or of lesser quality; it is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Specific disclosure information for the 2017 Annual Meeting is conveniently located online at college.acaai.org/disclosures

    Course summary
    Available credit: 
    • 1.25 AMA PRA Category 1 Credit™
    • 1.25 Attendance
    • 1.25 MOC
    Course opens: 
    10/30/2017
    Course expires: 
    10/30/2020
    Cost:
    $35.00
    Rating: 
    0
    • Michasel Wechsler, MD
    • Paul O'Byrne, MD
    • Peter Barnes, MD
    • Jeffrey Drazen, MD

    Available Credit

    • 1.25 AMA PRA Category 1 Credit™
    • 1.25 Attendance
    • 1.25 MOC

    Accreditation Period

    Course opens: 
    10/30/2017
    Course expires: 
    10/30/2020

    Price

    Cost:
    $35.00
    Please login or create an account to take this course.